news

« BACK

Pharmacology



Results 21 - 40 of 629.


Health - Pharmacology - 28.02.2022
Significant impacts of severe COVID-19 infection on pregnancy outcomes
Significant impacts of severe COVID-19 infection on pregnancy outcomes
A new analysis from Oxford Population Health has found that pregnant women that are 30 years old or more, overweight, of mixed ethnicity or have gestational diabetes have a greater risk of contracting severe COVID-19, which poses significant risks for both mother and baby. Throughout the COVID-19 pandemic, increasing evidence has shown that severe COVID-19 infection in pregnant women significantly raises the risk of adverse outcomes for both mother and baby.

Health - Pharmacology - 17.02.2022
Review highlights impact of Long COVID on cardiovascular system
Review highlights impact of Long COVID on cardiovascular system
The wide-ranging effects of Long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of Long COVID impact on the cardiovascular system. The review, published in the European Heart Journal , was conducted by researchers from the University of Oxford, the University of Wisconsin School of Medicine and Public Health, Royal Brompton Hospital and Imperial College, London, and the University of Zurich, Switzerland.

Health - Pharmacology - 15.02.2022
Cancer computer models identify new drug combinations to treat Covid-19
Cancer computer models identify new drug combinations to treat Covid-19
By adapting computer models originally developed to understand the biology of cancer cells, UCL scientists have identified new drug combinations with the potential to treat severe cases of Covid-19 infection at different stages of the disease. Researchers say the findings could help lower the number of Covid-19 related deaths and reduce the strain on healthcare systems.

Economics / Business - Pharmacology - 14.02.2022
New book highlights how small biotech companies are outperforming big pharma
Biotech firms have developed nearly 40% more of key treatments for unmet medical needs, says a new book co-authored by Cambridge researchers. From Breakthrough to Blockbuster: The Business of Biotechnology , published today, shows how the small, inexperienced entrepreneurial companies making up the biotech industry have created more life-changing medicines than all of the large pharmaceutical companies combined.

Health - Pharmacology - 02.02.2022
Cancer drug could help fight HIV - new research
Stock-photo-female-medical-or-research-scientist-or-doctor-using-looking-at-a-test-tube-of-clear-solution-in-a-595303463.jpg A cancer drug called pembrolizumab might also help people with HIV, according to a new study. On the face of it, cancer and Aids have little to do with each other. One is caused by an excessive division of cells in the body, the other is caused by infection with a virus (HIV).

Health - Pharmacology - 31.01.2022
Individuals with immunodeficiency at high risk of mortality following SARS-CoV-2 infection
Patients with primary and secondary immunodeficiency are at higher risk of mortality following SARS-CoV-2 infection compared with the general population, according to a new study led by the University of Birmingham. The COVID-19 pandemic has disproportionately affected individuals with primary immunodeficiency (PID) and secondary immunodeficiency (SID).

Pharmacology - Health - 28.01.2022
Impaired antibody response to COVID-19 vaccination in blood cancer and arthritis patients being treated with widely used drug
Study shows impaired antibody response to COVID-19 vaccination in blood cancer and arthritis patients being treated with widely used drug Certain blood cancer and arthritis patients have a significantly reduced antibody response to double COVID-19 vaccination in the first six months of being treated with a widely used drug, reveals a new study.

Pharmacology - Health - 26.01.2022
Study profiles side-effects linked to common immunosuppressant
Study profiles side-effects linked to common immunosuppressant
New research led by University of Manchester and NIHR Manchester Biomedical Research Centre (BRC) scientists has profiled the side effects of methotrexate - a common drug used to treat arthritis and other autoimmune diseases. The authors hope their findings - published today in journal Rheumatology - will ease the concerns of patients before commencing treatment, who often lack knowledge of the drug, its impact and side effects.

Health - Pharmacology - 20.01.2022
More than a third of care home residents caught Covid-19 in early waves of pandemic
More than a third of care home residents caught Covid-19 in early waves of pandemic
More than a third of care home residents and a quarter of care home staff in England showed evidence of infection with SARS-CoV-2 during the first two waves of the pandemic, according to a new study led by UCL researchers. The study, published in The Lancet Healthy Longevity , looked at blood samples from nearly 5,000 residents (with a median age of 87) and staff (with a median age of 48) at 201 care homes across England between June 2020 and May 2021.

Pharmacology - Health - 19.01.2022
New blood cancer gene defect can be treated with existing drugs
A defective gene normally found in blood cancers could be treated with drugs already available for cancers with similar gene defects, scientists at the University of Birmingham and Queen's University Belfast have revealed. The researchers believe that PARP inhibitors could be used to treat patients with tumours carrying the defective SF3B1 gene.

Health - Pharmacology - 18.01.2022
'Off target' effects of drugs used for autoimmune disorders needs better treatment strategy
’Off target’ effects of drugs used for autoimmune disorders needs better treatment strategy
New therapies for autoimmune rheumatic diseases (AIRDs) that are designed to better regulate lipid (fat) metabolism, could significantly reduce the harmful side-effects caused by conventional treatments, finds a new large-scale review led by UCL researchers. AIRDs affect millions globally and include rheumatoid arthritis, lupus and Sjögren's syndrome - all with high rates of morbidity.

Pharmacology - Life Sciences - 13.01.2022
Promising novel treatment for Dry Eye Disease revealed by new research
Promising novel treatment for Dry Eye Disease revealed by new research
The University of Manchester, Seoul National University College of Medicine and Link Biologics Limited today announced that promising preclinical data on the treatment of Dry Eye Disease using a novel protein biological drug, Link_TSG6, have been published in the peer-reviewed journal, Ocular Surface .

Physics - Pharmacology - 13.01.2022
Keeping up with the first law of robotics: A new photonic effect for accelerated drug discovery
Keeping up with the first law of robotics: A new photonic effect for accelerated drug discovery
Physicists at the University of Bath and University of Michigan demonstrate a new photonic effect in semiconducting nanohelices. A new photonic effect in semiconducting helical particles with nanoscale dimensions has been discovered by an international team of scientists led by researchers at the University of Bath.

Health - Pharmacology - 05.01.2022
New test can identify if a patient has cancer and if it has spread
New test can identify if a patient has cancer and if it has spread
A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. A University of Oxford study published in Clinical Cancer Research , a journal of the American Association for Cancer Research, outlines a new type of blood test that can be used to detect a range of cancers and whether these cancers have spread (metastasised) in the body.

Health - Pharmacology - 04.01.2022
Superbug MRSA arose in hedgehogs long before clinical use of antibiotics
Superbug MRSA arose in hedgehogs long before clinical use of antibiotics
Scientists have found evidence that a type of the antibiotic resistant superbug MRSA arose in nature long before the use of antibiotics in humans and livestock, which has traditionally been blamed for its emergence.

Health - Pharmacology - 04.01.2022
Easy-to-take medicine better at suppressing HIV in children
Easy-to-take medicine better at suppressing HIV in children
A once-a-day antiretroviral medicine that is low-cost and easy for children to take is also more effective at suppressing HIV than standard treatments, according to a global trial led by researchers at UCL. The study, published today in The New England Journal of Medicine , found that dolutegravir-based regimens, which are already widely used to treat adults, reduced the chances of treatment failure among young people aged three to 18 by around 40% compared to standard treatments.

Health - Pharmacology - 03.01.2022
Scale of prevalence of a condition that can cause type 2 diabetes and high blood pressure
Scientists at the University of Birmingham are calling for changes to healthcare policy following research which has shown for the first time the scale of the impact of a condition associated with benign tumours that can lead to type 2 diabetes and high blood pressure. Up to 10 per cent of adults have a benign tumour, or lump, known as an 'adrenal incidentaloma' in their adrenals - glands situated on top of the kidneys which produce a variety of hormones.

Pharmacology - Health - 23.12.2021
Abiraterone could halve risk of prostate cancer death for some patients
Abiraterone could halve risk of prostate cancer death for some patients
Adding abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death from the disease, according to the results of a UCL-led trial. The researchers suggest that hormone therapy using abiraterone with prednisolone, could significantly reduce prostate cancer deaths and improve outcomes for thousands of people every year.

Health - Pharmacology - 22.12.2021
Booster vaccination strongly enhances COVID-19 immunity in care home residents and staff - study
Booster vaccination strongly enhances COVID-19 immunity in care home residents and staff - study
A COVID-19 booster vaccination markedly increases immune response in residents and staff within care homes, making it vital that people living and working in these settings get their third 'jab', a new study reveals. Age and frailty are already recognised as major risk factors for severe COVID-19 outcomes, with elderly residents of long-term care facilities suffering much higher rates of mortality during the pandemic than the general population.

Health - Pharmacology - 22.12.2021
2021’s news highlights from the Faculty of Biology, Medicine and Health
Whether it's the continued impact of the Covid-19 pandemic or our world-leading science, our stories have been top news across the country and the world. Here's some of the most popular and interesting news releases from the Faculty of Biology, Medicine and Health in 2021.